Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19

Stopped Difficulty recruiting

Conditions

• Covid-19

Interventions

• BIOLOGICAL: COVI-GUARD
• OTHER: Standard of Care
• DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.